Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs.

Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE.

BMC Genet. 2007 Apr 3;8:10.

2.

Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C.

Arch Gen Psychiatry. 2008 Jun;65(6):683-93. doi: 10.1001/archpsyc.65.6.683.

3.

Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement.

Uhl GR, Drgon T, Johnson C, Ramoni MF, Behm FM, Rose JE.

Mol Med. 2010 Nov-Dec;16(11-12):513-26. doi: 10.2119/molmed.2010.00052. Epub 2010 Aug 24.

4.

Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.

Leventhal AM, Lee W, Bergen AW, Swan GE, Tyndale RF, Lerman C, Conti DV.

Drug Alcohol Depend. 2014 May 1;138:109-17. doi: 10.1016/j.drugalcdep.2014.02.016. Epub 2014 Mar 5.

5.

Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.

Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C.

Neuropsychopharmacology. 2010 May;35(6):1374-82. doi: 10.1038/npp.2010.7. Epub 2010 Feb 10.

6.

Genome-wide association for methamphetamine dependence: convergent results from 2 samples.

Uhl GR, Drgon T, Liu QR, Johnson C, Walther D, Komiyama T, Harano M, Sekine Y, Inada T, Ozaki N, Iyo M, Iwata N, Yamada M, Sora I, Chen CK, Liu HC, Ujike H, Lin SK.

Arch Gen Psychiatry. 2008 Mar;65(3):345-55. doi: 10.1001/archpsyc.65.3.345.

PMID:
18316681
7.

Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes.

Drgon T, Johnson C, Walther D, Albino AP, Rose JE, Uhl GR.

Mol Med. 2009 Jul-Aug;15(7-8):268-74. doi: 10.2119/molmed.2009.00040. Epub 2009 Apr 29.

8.

A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke.

Jensen KP, Smith AH, Herman AI, Farrer LA, Kranzler HR, Sofuoglu M, Gelernter J.

Mol Psychiatry. 2017 Feb;22(2):242-249. doi: 10.1038/mp.2016.43. Epub 2016 Apr 12.

9.

Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.

De Ruyck K, Nackaerts K, Beels L, Werbrouck J, De Volder A, Meysman M, Salhi B, Van Meerbeeck J, Thierens H.

Pharmacogenomics. 2010 Aug;11(8):1053-63. doi: 10.2217/pgs.10.75.

PMID:
20712524
10.

Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence.

Turner JR, Ray R, Lee B, Everett L, Xiang J, Jepson C, Kaestner KH, Lerman C, Blendy JA.

Mol Psychiatry. 2014 Jul;19(7):801-10. doi: 10.1038/mp.2013.104. Epub 2013 Sep 3.

11.

Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers.

Drgon T, Montoya I, Johnson C, Liu QR, Walther D, Hamer D, Uhl GR.

Mol Med. 2009 Jan-Feb;15(1-2):21-7. doi: 10.2119/molmed.2008.00096. Epub 2008 Oct 2.

12.

Smoking behavior on the first day of a quit attempt predicts long-term abstinence.

Westman EC, Behm FM, Simel DL, Rose JE.

Arch Intern Med. 1997 Feb 10;157(3):335-40.

PMID:
9040302
13.
14.

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

David SP, Johnstone EC, Murphy MF, Aveyard P, Guo B, Lerman C, Munafò MR.

Drug Alcohol Depend. 2008 Nov 1;98(1-2):77-85. doi: 10.1016/j.drugalcdep.2008.04.013. Epub 2008 Jun 17.

15.

Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.

Rose JE, Herskovic JE, Behm FM, Westman EC.

Nicotine Tob Res. 2009 Sep;11(9):1067-75. doi: 10.1093/ntr/ntp103. Epub 2009 Jun 30.

PMID:
19567826
16.

Genetics of nicotine dependence and pharmacotherapy.

Lessov-Schlaggar CN, Pergadia ML, Khroyan TV, Swan GE.

Biochem Pharmacol. 2008 Jan 1;75(1):178-95. Epub 2007 Aug 19. Review.

17.

Smoking and smoking cessation in disadvantaged women: assessing genetic contributions.

Uhl GR, Drgon T, Li CY, Johnson C, Liu QR.

Drug Alcohol Depend. 2009 Oct 1;104 Suppl 1:S58-63. doi: 10.1016/j.drugalcdep.2009.03.012. Epub 2009 May 12. Review.

PMID:
19442458
18.

A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.

Loukola A, Buchwald J, Gupta R, Palviainen T, Hällfors J, Tikkanen E, Korhonen T, Ollikainen M, Sarin AP, Ripatti S, Lehtimäki T, Raitakari O, Salomaa V, Rose RJ, Tyndale RF, Kaprio J.

PLoS Genet. 2015 Sep 25;11(9):e1005498. doi: 10.1371/journal.pgen.1005498. eCollection 2015.

19.

SNPs within CHRNA5-A3-B4 and CYP2A6/B6 are associated with smoking dependence but not with tobacco dependence treatment outcomes in the Czech population.

Hubacek JA, Pankova A, Stepankova L, Zvolska K, Adamkova V, Lanska V, Kralikova E.

Gene. 2017 Mar 30;606:35-38. doi: 10.1016/j.gene.2017.01.005. Epub 2017 Jan 6.

PMID:
28069549
20.

Incorporating age at onset of smoking into genetic models for nicotine dependence: evidence for interaction with multiple genes.

Grucza RA, Johnson EO, Krueger RF, Breslau N, Saccone NL, Chen LS, Derringer J, Agrawal A, Lynskey M, Bierut LJ.

Addict Biol. 2010 Jul;15(3):346-57. doi: 10.1111/j.1369-1600.2010.00220.x.

Supplemental Content

Support Center